41,028 Shares in HealthEquity, Inc. $HQY Bought by EFG International AG

EFG International AG purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, Holdings Channel.com reports. The firm purchased 41,028 shares of the company’s stock, valued at approximately $3,706,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of HQY. Oxbow Advisors LLC bought a new stake in HealthEquity during the first quarter worth $3,147,000. Deutsche Bank AG acquired a new stake in HealthEquity in the second quarter valued at $11,986,000. Maridea Wealth Management LLC bought a new position in shares of HealthEquity in the 2nd quarter valued at about $2,753,000. Westfield Capital Management Co. LP grew its position in shares of HealthEquity by 13.7% in the 4th quarter. Westfield Capital Management Co. LP now owns 1,952,452 shares of the company’s stock valued at $178,864,000 after acquiring an additional 235,794 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd acquired a new position in shares of HealthEquity during the 4th quarter worth about $4,381,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at $5,615,735. This represents a 5.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 7,966 shares of company stock valued at $756,770. 1.60% of the stock is currently owned by corporate insiders.

HealthEquity Price Performance

NASDAQ:HQY opened at $104.42 on Thursday. The company has a market cap of $8.73 billion, a P/E ratio of 39.11, a P/E/G ratio of 1.77 and a beta of 0.21. The firm’s fifty day moving average price is $97.77 and its two-hundred day moving average price is $87.71. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $107.62. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business’s quarterly revenue was up 7.2% on a year-over-year basis. Equities analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of research analyst reports. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Weiss Ratings upgraded HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, June 5th. Citizens Jmp boosted their price target on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. KeyCorp restated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a research report on Friday, May 22nd. Eleven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $110.93.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.